In AD, where ADE complement effector levels are elevated and in elderly control subjects with much lower ADE levels of C3b and C5b-9, mean levels of C5b-9 were 1.49% and 2.68% of those of C3b, respectively. Here, C3 is linked to Alzheimer disease.